MedTrace Logo

MORA Cure for Knee Osteoarthritis With Anterior Knee Pain

NCT07769593 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-08-18

No results posted yet for this study

Summary

This prospective, multicenter, single-arm, sponsor-initiated pilot study will evaluate the clinical course and safety of MORA Cure in adults older than 50 years with knee osteoarthritis accompanied by anterior knee pain. Participants will use MORA Cure for 8 weeks. MORA Cure provides personalized rehabilitation exercises and cognitive behavioral therapy-based content through a patient mobile application supported by a clinician web portal. Clinical outcomes will be assessed at baseline, Week 4, and Week 8. The planned enrollment is 44 participants at two sites in the Republic of Korea.

Conditions

Interventions

DEVICE

MORA Cure

MORA Cure consists of a clinician web program (ETH-01KW) and a patient mobile application (ETH-01K). At baseline, the investigator registers the participant and issues a prescription code. The participant installs the application and uses it for 8 weeks. The application collects symptom information and AI-based movement assessment results, provides personalized rehabilitation exercises at least 3 times per week for approximately 30 minutes per session, adjusts exercise load based on participant data, and provides weekly cognitive behavioral therapy content. The application is deleted at Week 8.

Sponsors & Collaborators

  • EverEx Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
51 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-10
Primary Completion
2026-09-10
Completion
2027-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07769593 on ClinicalTrials.gov